What matters to patients and clinicians when discussing the impact of cancer medicines on health-related quality of life? Consensus-based mixed methods approach in prostate cancer
Sign Up to like & getrecommendations! Published in 2021 at "Supportive Care in Cancer"
DOI: 10.1007/s00520-021-06724-6
Abstract: To identify what matters to clinicians and patients when discussing cancer medicines’ impact on health-related quality of life (HRQoL). A framework of HRQoL domain/domain elements was developed, informed by analysis of published patient reported outcome… read more here.
Keywords: cancer; cancer medicines; discussing impact; health related ... See more keywords
Access to High Cost Cancer Medicines Through the Lens of an Australian Senate Inquiry—Defining the “Goods” at Stake
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Bioethical Inquiry"
DOI: 10.1007/s11673-017-9800-2
Abstract: Cancer is a major burden on populations and health systems internationally. The development of innovative cancer medicines is seen as a significant part of the solution. These new cancer medicines are, however, expensive, leading to… read more here.
Keywords: cancer; cancer medicines; senate inquiry; access high ... See more keywords
What Does Society Value About Cancer Medicines? A Discrete Choice Experiment in the Belgian Population
Sign Up to like & getrecommendations! Published in 2019 at "Applied Health Economics and Health Policy"
DOI: 10.1007/s40258-019-00504-4
Abstract: BackgroundDebate on pricing and reimbursement of cancer medicines highlights the need to establish the value of cancer medicines.ObjectiveThis study aims to elicit the trade-offs in cancer medicine characteristics that the Belgian population is willing to… read more here.
Keywords: cancer medicines; value; cancer; quality life ... See more keywords
Pharmacovigilance of anti-cancer medicines: opportunities and challenges
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2020.1772751
Abstract: ABSTRACT Introduction The foundations of pharmacovigilance are the monitoring of drug safety in real-world medicine, and identification of new adverse effects, unknown at the time of market approval. Cancer patients are prone to adverse drug… read more here.
Keywords: cancer medicines; pharmacovigilance anti; drug; cancer ... See more keywords
Cancer medicines in Asia and Asia-Pacific: What is available, and is it effective enough?
Sign Up to like & getrecommendations! Published in 2019 at "ESMO Open"
DOI: 10.1136/esmoopen-2018-000483
Abstract: This review article is an overview of the session at the European Society for Medical Oncology (ESMO) Asia 2018 Congress entitled: 'Cancer medicines in Asia and Asia-Pacific: What is available, and is it effective enough?'.… read more here.
Keywords: cancer medicines; asia pacific; medicines asia; asia asia ... See more keywords
Ensuring Global Access to Cancer Medicines: A Generational Call to Action.
Sign Up to like & getrecommendations! Published in 2023 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-22-1372
Abstract: SUMMARY Essential cancer treatments are not accessible, affordable, or available to patients who need them in many parts of the world. A new Access to Oncology Medicines (ATOM) Coalition, using public-private partnerships, aims to bring… read more here.
Keywords: cancer medicines; ensuring global; access cancer; global access ... See more keywords
A comprehensive survey of cancer medicines prices, availability and affordability in Ghana
Sign Up to like & getrecommendations! Published in 2023 at "PLOS ONE"
DOI: 10.1371/journal.pone.0279817
Abstract: Introduction In Ghana, prices for cancer medicines are characterized by high retail markups, forex fluctuations and high variation in prices of medicines. Most patients cannot afford the cancer medicines. There is a problem of unaffordability… read more here.
Keywords: cancer medicines; hospitals private; availability; price ... See more keywords
Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.873556
Abstract: Background: Rising expenditure for new cancer medicines is accelerating concerns that their costs will become unsustainable for universal healthcare access. Moreover, early market access of new oncology medicines lacking appropriate clinical evaluation generates uncertainty over… read more here.
Keywords: european countries; oncology; health authority; cancer medicines ... See more keywords